Unveiling a Revolutionary Approach to Drug Discovery through Proteomics and Genetics
Originally Published 2 years ago — by Endpoints News
The Pharma Proteomics Project, a collaboration between 13 pharmaceutical companies and the UK Biobank, has discovered numerous new leads for drug targets and diagnostic biomarkers by analyzing genetic data and blood proteins from 54,000 individuals. This research has the potential to uncover the causes of common conditions and has revealed thousands of previously unknown associations between common genetic variants and circulating proteins in the blood.